BFC Planning’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
BFC Planning's IDXX Position: Q3 2026 in Review
BFC Planning reduced its Idexx Laboratories (IDXX) stake by 91% in Q3 2026, selling an estimated $519K and leaving 89 shares worth $46.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1590.
BFC Planning first reported a position in IDXX in Q3 2024 and has held it in 9 quarters since. The position peaked at $583K in Q4 2025. 1,104 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.
- BFC Planning held 89 shares of Idexx Laboratories worth $46.5K as of Q3 2026.
- BFC Planning sold 947 Idexx Laboratories shares in Q3 2026, an estimated $519K.
- Idexx Laboratories made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1590 holding.
- BFC Planning first reported a position in Idexx Laboratories in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Idexx Laboratories position peaked at $583K in Q4 2025.
- 1,104 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.